Thursday, June 28, 2018
12:00 PM – 1:00 PM
Meningococcal disease, specifically serotype B (MenB), is an ongoing problem in this country, particularly in university outbreaks. Meningococcal disease is a serious illness that can develop from initial symptoms to death within 24 hours. It often occurs without warning – even among people who are otherwise healthy. Presenters in this webinar will discuss the disease burden of the meningococcal disease, specifically meningococcal B, the ACIP recommendation for MenB vaccination and the meaning of Category B recommendation, as well as strategies for improving MenB vaccination rates in your clinic.
Objectives: At the conclusion of this activity, participants will be able to (or better able to):
1. Discuss the current epidemiology of meningococcal B in the United States and the profiles of patients at greatest risk for this vaccine-preventable disease.
2. Describe MenB vaccine recommendations made by the Advisory Committee on Immunization Practices (ACIP) and the rationale behind a category B classification.
3. Recognize best practices in counseling patients and their parents/caregivers on the importance of administering the MenB vaccine
4. Discuss practice considerations for administering the MenB vaccine such as documentation, billing, and screening for additional immunizations.
1. Jeff Neccuzi, Director, Division of Immunization Services, West Virginia Bureau for Public Health
2. Angela Gray, BSN, RN, Nurse Director, RWJF Public Health Nurse Leader, Berkeley County Health Department